Clinical Trial Update: M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) [Phase 1]

View source ↗

Summary

Phase 1 study of M9466 in combination with Topoisomerase 1 inhibitors for advanced solid tumors, including colorectal cancer, was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• M9466

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: TERMINATED